Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,580,860
-
Total 13F shares
-
6,406,279
-
Share change
-
+1,987,644
-
Total reported value
-
$103,764,502
-
Price per share
-
$16.20
-
Number of holders
-
53
-
Value change
-
+$32,713,006
-
Number of buys
-
38
-
Number of sells
-
18
Institutional Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q2 2019
As of 30 Jun 2019,
OptimizeRx Corp - Common Stock (OPRX) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,406,279 shares.
The largest 10 holders included
Park West Asset Management LLC, WOLVERINE ASSET MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, WASATCH ADVISORS INC, G2 Investment Partners Management LLC, CALAMOS ADVISORS LLC, 1492 Capital Management LLC, Russell Investments Group, Ltd., and Manatuck Hill Partners, LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.